CHEYENNE, Wyo., March 20, 2018 -- MJ Biotech, Inc. (FKA Michael James Enterprises, Inc.) (OTC:MJTV) announced that it executed a Joint Venture agreement with Marijuana Doctors.com located in Florida to provide CBD Teas manufactured by Zen’s Tea House. The CBD Teas will be sold at all the Marijuana Doctors Florida locations.
MarijuanaDoctors.com was founded as the trusted gateway for patients searching for medical marijuana treatment in legal medical marijuana states. We provide patients visibility and transparency in selecting a doctor and setting an appointment for a medical marijuana evaluation including detailed profile information, scheduling information, and ratings and reviews. We understand the uncertainty associated with the process and that medical marijuana is often the only effective treatment for many ailments for which traditional medicine provides little relief or is accompanied by uncomfortable and dangerous side effects.
Conference Call update.
The Conference call update will be delayed due to the most recent Joint Venture agreement. The new date will be announced this week.
Due to the new Joint Venture agreement if there are additional questions regarding this Press Release please send them to [email protected].
Also Fernando Lopez the COO of MJ Biotech and President of Zen Tea House just did a new face book live with a Certified Holistic Nutritionist (FNS, CNPM, CHNP) about the benefits of teas & nutrition. This video can be seen at Facebook at https://www.facebook.com/zensteahouse.
Additional information is available on the company’s websites, www.mjbiotech.us and www.zenstea.com
Safe Harbor Statement
This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as "would," "may," "will," "expects," and other terms with similar meaning. Forward-looking statements are based on current beliefs, assumptions and expectations and speak only as of the date of this release and involve risks and uncertainties that could cause actual results to differ materially from current expectations. We assume no obligation to update or revise any forward-looking statement, whether because of new information, future events or any other reason.
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Contact
Fernando Lopez
[email protected]


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Instagram Outage Disrupts Thousands of U.S. Users
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Washington Post Publisher Will Lewis Steps Down After Layoffs
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 



